Loading clinical trials...
Loading clinical trials...
Effect of Gui-Lu-Er-Xian-Jiao-Wan on Intradialytic Hypotension: a Randomized Crossover Pilot Trial
Intradialytic hypotension (IDH), a common complication during hemodialysis (HD) could increase patients' morbidity and mortality. Previous studies considered that some Chinese herbal medicine (CHM) plays a complementary role in reducing the frequency of IDH. This trial is aimed to investigate the effect of Gui-Lu-Er-Xian-Jiao-Wan (GLEXJW) in patients with intradialytic hypotension.
Age
20 - 80 years
Sex
ALL
Healthy Volunteers
No
Kaohsiung Chang Gung Memorial Hospital
Kaohsiung City, Taiwan
Start Date
September 1, 2022
Primary Completion Date
July 31, 2024
Completion Date
December 31, 2024
Last Updated
August 26, 2022
50
ESTIMATED participants
Gui-Lu-Er-Xian-Jiao-Wan
DRUG
Lead Sponsor
Chang Gung Memorial Hospital
NCT04163614
NCT05936710
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07179705